NxThera logo — Pioneering minimally invasive vapor therapy to enhance urina...

NxThera

Pioneering minimally invasive vapor therapy to enhance urinary flow and quality of life for millions of men battling BPH.

Founded 2008 Debt Financing Total: $123.49M Biotechnology, Health Care +1

General Information

Company Name NxThera
Founded Year 2008
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with NxThera. To contact NxThera, visit nxthera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NxThera compare?

A PDF of NxThera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NxThera soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NxThera

NxThera is a biotechnology company founded in 2008 that focuses on developing medical technologies to address endourology conditions, specifically benign prostatic hyperplasia (BPH). The company's slogan highlights its goal of improving the urinary flow and quality of life for the millions of men affected by BPH. Their technology platform utilizes a minimally invasive vapor therapy, offering a straightforward approach to alleviate urinary flow issues and enhance patient well-being. Notably, BPH affects more than 32 million men in the United States, demonstrating a substantial market potential. In July 2017, NxThera secured a $6.02M Debt Financing investment, signifying investor confidence in the company's innovative approach and market opportunity. The success of this investment demonstrates the industry's recognition of NxThera's potential to address a significant medical need while offering a viable business opportunity. As a result, NxThera's pioneering technology and strategic focus on addressing BPH position the company at the forefront of the medical devices and health care sectors, making it an attractive prospect for venture capital investors seeking opportunities in the biotechnology and medical technology landscape.

Business keywords: minimally invasive surgery, vapor therapy, endourology, BPH treatment, urinary flow improvement, patient quality of life

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $6.02M -
19 Jul 2017
Series E $15.30M -
03 Feb 2017
Series D $40.00M 3
Mitsui Global Investment, Boston Scientific +1
03 Dec 2015
Debt Financing $3.00M -
10 Feb 2015
Series C $25.00M 1
Perseverance Capital Management
26 Feb 2014
Venture Round $6.57M -
24 Sep 2013
Series B $21.60M 3
Aberdare Ventures, Arboretum Ventures +1
04 Oct 2011
Series A $6.00M 1
Bonsal Capital
01 Jan 2008

NxThera Alternatives & Competitors

View All Alternatives
NxThera vs

Vena Medical | The Vena Microcatheter

Seed
25 employees
Biotechnology, Health Care
NxThera vs
BlueWind Medical
BlueWind Medical United States

BlueWind is an innovative medical device company that aims to transform neuromodulation therapy for...

Series B
121 employees
Biotechnology, Health Care
NxThera vs
Monteris Medical
Monteris Medical United States

Advancing Science. Transforming Lives.

Debt Financing
114 employees
Biotechnology, Health Care

FAQ About NxThera

Pioneering minimally invasive vapor therapy to enhance urinary flow and quality of life for millions of men battling BPH.
NxThera was founded in 2008.
NxThera operates in Biotechnology, Health Care and Medical Devices. Its work centres on minimally invasive surgery, vapor therapy, endourology and BPH treatment.
NxThera has completed 8 funding rounds, raising a total of $123.49M. The latest funding stage is Debt Financing.
Top alternatives and competitors to NxThera include Vena Medical, BlueWind Medical, Monteris Medical, Zenflow, Inc., Sanoculis Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NxThera and Vena Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NxThera, https://bouncewatch.com/company/nxthera, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes